Hu23F2G monoclonal antibody: Phase II Update

ICOS started a Phase II trial in 200 MS patients

Read the full 100 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE